Chylous ascites after liver transplantation: Incidence and risk factors
Mehmet Yilmaz, Sami Akbulut, Burak Isik, Cengiz Ara, Fatih Ozdemir, Cemalettin Aydin, Cuneyt Kayaalp, Sezai Yilmaz – 25 May 2012 – In this study, we evaluated the diagnosis, epidemiology, risk factors, and treatment of chylous ascites developing after liver transplantation (LT). Between 2002 and 2011, LT was performed 693 times in 631 patients at our clinic. One‐hundred fifteen of these patients were excluded for reasons such as retransplantation, early postoperative mortality, and insufficient data.
Clinical factors predicting readmission after orthotopic liver transplantation
Arema A. Pereira, Renuka Bhattacharya, Robert Carithers, Jorge Reyes, James Perkins – 25 May 2012 – Hospitals with the highest readmission rates for high‐cost conditions may be targeted for payment penalties. The primary aim of this study was to determine clinical predictors of 30‐day readmission after discharge for patients undergoing orthotopic liver transplantation (OLT) at the University of Washington from January 2003 to October 2010.
Reply
A. Sidney Barritt, Eric S. Orman, Paul H. Hayashi – 25 May 2012
Reply
Shirish Huprikar, Gopi Patel, Thomas Schiano, Jayant Kalpoe – 25 May 2012
Prognostic impact of off‐hour liver transplants on graft and survival outcomes
Palaniappan Manickam – 25 May 2012
Liver transplantation for alagille syndrome: The jagged edge
Benjamin L. Shneider – 25 May 2012
Sirolimus: More cause for alarm?
Parul D. Agarwal, Michael R. Lucey – 25 May 2012
Right diaphragmatic defect in hepatic hydrothorax exposed by contrast‐enhanced ultrasonography after radiofrequency ablation
Tomomitsu Matono, Masahiko Koda, Yoshikazu Murawaki – 23 May 2012 – A 68‐year‐old male with liver cirrhosis and hepatocellular carcinoma treated by radiofrequency ablation was hospitalized for right hepatic hydrothorax and ascites. Perflubutane injected into the peritoneal cavity after an ultrasonography contrast agent revealed jet‐like flow from the ascites to a pleural effusion, indicating a diaphragmatic defect. A hepatic hydrothorax was sutured under thoracoscopy and did not recur. An intraperitoneal injection of perflubutane enables a less‐invasive diagnosis of a diaphragmatic defect.
Right diaphragmatic defect in hepatic hydrothorax exposed by contrast‐enhanced ultrasonography after radiofrequency ablation
Tomomitsu Matono, Masahiko Koda, Yoshikazu Murawaki – 23 May 2012 – A 68‐year‐old male with liver cirrhosis and hepatocellular carcinoma treated by radiofrequency ablation was hospitalized for right hepatic hydrothorax and ascites. Perflubutane injected into the peritoneal cavity after an ultrasonography contrast agent revealed jet‐like flow from the ascites to a pleural effusion, indicating a diaphragmatic defect. A hepatic hydrothorax was sutured under thoracoscopy and did not recur. An intraperitoneal injection of perflubutane enables a less‐invasive diagnosis of a diaphragmatic defect.